This site is intended for healthcare professionals
News

ENVISION Phase III study results of Givlaari to treat acute hepatic porphyria were published online in the NEJM.- Alnylam Pharma

Read time: 1 mins
Last updated:12th Jun 2020
Published:12th Jun 2020
Condition: Porphyria
Type: drug
Register free for full access to medthority.com